Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPH | LTRN | KYNB | ||
| Company | Orphazyme A/S ADR | Lantern Pharma Inc | Kyntra Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.9060 | 2.71 | 7.11 | ||
| High | 0.9571 | 2.75 | 7.29 | ||
| Low | 0.8457 | 2.60 | 7.03 | ||
| Latest | 0.8700 | 2.70 | 7.12 | ||
| Change | -0.0200 | -0.06 | -0.01 | ||
| % Change | -2.25% | -2.17% | -0.14% | ||
| Volume | 941,400 | 31,802 | 7,441 | ||
| 20-Day Average Volume | 1,980,090 | 48,590 | 39,882 | ||
| Previous Close | 0.8900 | 2.76 | 7.13 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.9128 | 2.73 | 7.33 | ||
| 20-Day Raw Stochastic | 41.76% | 39.06% | 19.40% | ||
| 20-Day Relative Strength | 36.52 | 43.62 | 43.13 | ||
| Weighted Alpha | -87.89 | -34.71 | -35.14 | ||
| Today's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 03/23/22 | -4.26% since 03/04/26 | +2.89% since 03/04/26 | ||
| Low | 0.8275 on 03/29/22 | 2.56 on 03/09/26 | 6.67 on 03/06/26 | ||
| High | 0.9600 on 03/29/22 | 2.83 on 03/05/26 | 7.65 on 03/09/26 | ||
| 1-Month | |||||
| %Chg | -28.69% since 02/28/22 | -5.26% since 02/11/26 | -8.72% since 02/11/26 | ||
| Low | 0.5101 on 03/14/22 | 2.45 on 02/23/26 | 6.67 on 03/06/26 | ||
| High | 1.3720 on 03/10/22 | 3.09 on 02/25/26 | 8.99 on 02/20/26 | ||
| 3-Month | |||||
| %Chg | -67.29% since 12/28/21 | -27.81% since 12/11/25 | -18.16% since 12/11/25 | ||
| Low | 0.5101 on 03/14/22 | 2.45 on 02/23/26 | 6.67 on 03/06/26 | ||
| High | 2.7500 on 01/03/22 | 3.78 on 12/12/25 | 10.47 on 12/16/25 | ||
| 6-Month | |||||
| %Chg | -79.33% since 09/28/21 | -31.30% since 09/11/25 | -42.72% since 09/11/25 | ||
| Low | 0.5101 on 03/14/22 | 2.45 on 02/23/26 | 6.67 on 03/06/26 | ||
| High | 5.4900 on 10/13/21 | 4.70 on 10/08/25 | 12.58 on 09/25/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 30,721 | 30,868 | 28,844 | ||
| Shares Outstanding, K | 35,312 | 11,184 | 4,045 | ||
| Annual Sales | 0 | 0 | 29,620,000 | ||
| Annual Net Income | -97,010,000 | -20,780,000 | -47,580,000 | ||
| Last Quarter Sales | N/A | 0 | 1,080,000 | ||
| Last Quarter Net Income | N/A | -4,180,000 | 200,640,000 | ||
| 60-Month Beta | 1.68 | 1.53 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.39 on 11/12/25 | -1.61 on 11/10/25 | ||
| Latest Earnings Date | 04/05/22 | 03/26/26 | 03/16/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||